Written answers

Tuesday, 15 September 2020

Department of Health

Medicinal Products

Photo of Joe O'BrienJoe O'Brien (Dublin Fingal, Green Party)
Link to this: Individually | In context | Oireachtas source

766. To ask the Minister for Health the status of the establishment of an independent inquiry to investigate the historical licensing and use of sodium valproate here; and if he will make a statement on the matter. [23872/20]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The issues and risks associated with the use of sodium valproate by women of childbearing age are well recognised by medicines regulators and healthcare professionals. Officials in the Department of Health, the HSE, and the Health Products Regulatory Authority are reviewing these issues at present, and considering the next steps that should be taken to minimise the risks involved in the use of this drug. The Minister is aware of requests by patient representative groups for an inquiry into the historical use of sodium valproate in Ireland, and will give further consideration to these requests.

Comments

No comments

Log in or join to post a public comment.